drugset / Trial / NCT02625740

Ultrasound to Enhance Paclitaxel Uptake in Critical Limb Ischemia: the PACUS Trial

NCT02625740

Completed 56 enrolled University of Rome Tor Vergata
RandomizedParallel-groupSingle-blindTreatment

Summary

The PACUS Trial was a single center, single blinded, randomized trial designed to evaluate the safety and efficacy of intravascular percutaneous catheter-delivered ultrasound energy to improve local Paclitaxel delivery effects in critical limb ischemia patients due to femoral-popliteal artery disease.

Timeline

Start
2013-11
Primary completion
2014-11
Completion
2015-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Paclitaxel Small molecule Other